As of 12:30 PM on the 24th, Baxel Bio is trading at 116,000 KRW, down 3.33% from the previous day. This represents a 25.68% increase compared to February 23.

Over the past five days, individual investors have sold a net 293,050 shares, while foreigners and institutions have bought a net 281,382 shares and 10,940 shares, respectively.


On March 19, Baxel Bio became a market topic with the headline "Will NK Cell-Based CAR-T Therapy Surpass Others?...0.36↑".



※Source: AI Investment Assistant AI Lasso


※ This article was generated in real-time by an automated article creation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing